AzTrials
AzTrials

Pre-TermNCT05383586

MusicHyperBrain Study With Preterm Infants and Their Parents

A study testing Creative Music Therapy in people with Pre-Term, run by University of Zurich at 1 site in Switzerland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Inter-personal brain coupling between preterm infants, their parents and a musician during Creative Music Therapy using functional near-infrared imaging (fNIRI) hyperscanning and systemic physiology measurements Read more about this study

Who is it for?
Ages 32 to 36 weeks
Conditions the study is for
Pre-Term
What is being tested?
Creative Music Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteSwitzerland
Study dates
3 Nov 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 32 to 36 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Clinically stable preterm infants (no invasive cardiovascular or ventilation support)
  • age: 7-21 days of life
  • born with 32 0/7 ≤ 36 6/7 weeks of gestation
  • mentally stable parents of the included infants

Who cannot join

  • admission for palliative care
  • congenital malformation
  • parental psychiatric disorders
  • parental language barriers

Trial locations and contacts

1 site in 1 country.

Friederike Haslbeck, PhD contact

+41 78 708 1862

friederike.haslbeck@usz.ch

Felix Scholkmann, PD, PhD contact

+41 44 255 53 45

felix.scholkmann@usz.ch

Switzerland1 site, 1 recruiting
  • University Hospital Zurich

    Zurich, 8091

    Friederike B Haslbeck, PhD, +41 78 708 1862, friederike.haslbeck@usz.ch

    Dirk Bassler, Prof., +41 44 2551111, dirk.bassler@usz.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: Inter-personal Brain Coupling Between Preterm Infants, Their Parents and a Musician During Creative Music Therapy Using Functional Near-infrared Imaging (fNIRI) Hyperscanning

Inter-personal brain coupling between preterm infants, their parents and a musician during Creative Music Therapy using functional near-infrared imaging (fNIRI) hyperscanning and systemic physiology measurements

Read the detailed description

Background Preterm infants represent a growing population in health care. Unfortunately, many infants suffer from neurodevelopmental impairments that persist into adolescence and adulthood. Besides other risk factors, auditory deprivation (e.g., the lack of exposure to regular intrauterine rhythms of the maternal heartbeat and the maternal voice), and the overwhelming stressful auditory environment of an intensive care unit may negatively impact brain maturation. Studies showed that infant-parent separation can impede the bidirectional development of physical, emotional, and psychological bonds between parents and their infants. Brain development is linked to nurturing social contact and early auditory experience, as demonstrated by human and animal studies. New studies showed, music is promoting neurobiological processes and neuronal learning in the human brain, which starts before birth.

Rationale Creative Music Therapy (CMT) provides meaningful interactions and a nurturing enrichment of the auditory environment by infant-directed singing in lullaby-style. Positive short-term music therapy outcomes (i.e., arousal, behavior, respiratory rate, maternal anxiety) have been shown in several reviews. Preliminary results of a recent pilot feasibility randomized controlled trial (RCT) suggest that functional brain connectivity as measured by resting-state functional magnet resonance imaging seems to have a possible early beneficial effect of CMT which manifests in (1) lower thalamo-cortical processing delay, (2) stronger functional networks, and (3) higher functional integration in predominantly left prefrontal, supplementary motor and inferior temporal brain regions. Depressive symptoms may be decreased and physical connectedness increased between infants and their parents with CMT. However, real time evaluation of CMT's possible immediate effect on the brain activity in infants and inter-personal synchronization processes between parents and infants have not been conducted yet.

The primary objective is to explore if CMT:

Improves inter-personal interaction between the infant, the parent (i.e. the mother or father) and the music therapist assessed via cerebral oxygenation synchronization between the infant and parent as well as the infant and the music therapist in the left auditory cortex and frontal cortex.

The secondary objectives are to explore if CMT:

  • synchronizes inter-personal emotional/ stress responses between infant, parents (and music therapist)
  • improves/ regulates brain activity in the infants' left auditory cortex and frontal cortex (evidenced by less fluctuations of cerebral hemodynamics and oxygenation)
  • reduces stress in the infants
  • reduces stress in the parents (mother or father)

Additionally, we aim to explore the parental perspective of CMT and their study participation.

Primary endpoint*:

Inter-personal synchronization of cerebral oxygenation and hemoglobin concentration in the brain between the infant and the parent as well as the infant and the music therapist measured by functional near-infrared spectroscopy (fNIRS) neuroimaging with a commercially available device approves for clinical applications (OxyPrem) in the left auditory and prefrontal cortex

Major secondary endpoints*:

  • Inter-personal synchronization/ coupling of systemic physiology (emotional/ stress responses) in the infant and the parent as well as in the infant and the music therapist measured by systemic physiological parameters (heart rate (HR), electrodermal activity (EDA), heart rate variability (HRV), respiration rate (RR))
  • Cerebral oxygenation activation/ regulation in the infant measured by fNIRS neuroimaging with OxyPrem in the left auditory and prefrontal cortex
  • Stress level in the infants measured by systemic parameters (HR, EDA, HRV)
  • Stress level in the parents measured by systemic parameters (EDA, HRV)
  • Parental perspective of CMT and study participation
  • 15 minutes before CMT (5 minutes without kangaroo/ 10 minutes in kangaroo), 20 minutes during kangaroo with CMT, and 10 minutes after CMT (10 minutes in kangaroo/ without kangaroo)/ first session of CMT during neonatal intensive care hospitalization in the second/third week after the preterm infant's birth

Intervention:

Once/second time 20 minutes CMT: entrained infant-directed live lullaby singing, accompanied with the vibro-acoustic monochord provided by the music therapist for infant and parents in kangaroo care as described in the published clinical practice protocol.

N= 20 infant-parent couples (effect size: 1.4; significance level: 0.05; power: 0.8)

Study duration:

  • Preparatory phase (months): 3 months
  • First patient to last patient in/recruitment/ intervention phase: 12 months
  • analysis: 2 months
  • Preparation publication: 3 months Duration of the entire trial (preparatory phase + study phase): 18 months

Statistical considerations:

Brain-to-brain coupling will be determined by coherence analysis based on the fNIRS signals measured. The time-dependent coherence changes will be analyzed statistically in order to see stat. significant changes during the task compared to the baseline. Synchronization of systemic physiological signals will be determined with the same approach. Statistical analysis will be performed with ANOVA and generalized additive models (GMAs).

Conditions
Pre-Term
Being tested
Creative Music Therapy
Keywords
music therapy, preterm infants, preterm parents, synchronization, hyperscanning, NIRS, HRV, oxyPrem
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Creative Music TherapyOther

    Creative Music Therapy is provided during kangaroo-care. It is an individualized, family- centered approach offering infant-directed humming and singing accompanied with the monochord.

Study groups in NCT05383586
Study groupRoleWhat they receive
Creative Music TherapyExperimental20 minutes of infant-directed singing in lullaby-style accompanied with the monochord for preterm infant and parent during kangaroo-care
Receives: Other: Creative Music Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inter-personal synchronization of cerebral oxygenation and hemoglobin concentration

    Inter-personal synchronization (determined by the time-dependent coherence calculated via Wavelet transform coherence) of cerebral oxygenation (StO2 in %) and total hemoglobin concentration ([tHb] in relative µM) time-series in the brain between the infant and the parent as well as the infant and the music therapist measured by functional near-infrared spectroscopy (fNIRS) neuroimaging with a commercially available device approves for clinical applications (OxyPrem) in the left auditory and prefrontal cortex. Both devices provide similar measurements of cerebral oxygenation and hemodynamics, i.e. relative changes in the concentration of oxyhemoglobin ([O2Hb] in relative µM) and deoxyhemoglobin ([HHb] in relative µM). These time-series will be first pre-processed (removal of artifacts, band-pass filtered (0.01-0.5 Hz)) and then analyzed (Wavelet coherence and subsequent statistical analysis via a generalized additive model and Bayesian analysis).

    Measured: 50 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2022
  2. Study start3 Nov 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
One single group will be included with a pre-during-post intervention design.
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05383586
Sponsor's protocol ID
2021-02414
Status last verified
May 2023
First submitted
19 Apr 2022
Last updated
16 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Creative Music Therapy in people with Pre-Term, run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Friederike Haslbeck, PhD (+41 78 708 1862, friederike.haslbeck@usz.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inter-personal synchronization of cerebral oxygenation and hemoglobin concentration (time frame: 50 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in